Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,8 USD | -4,76% | -20,79% | -45,95% |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Drug Development
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -92,24% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -92,24% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 52 | 05/01/23 | |
Director of Finance/CFO | 62 | 01/07/23 | |
Chief Tech/Sci/R&D Officer | - | 01/07/23 | |
Julie Kerner
COO | Chief Operating Officer | - | 01/07/23 |
Liz Doolin
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/08 |
Adrian Hinton
AUD | Comptroller/Controller/Auditor | 72 | 01/05/19 |
Rajeev Chandra
SEC | Corporate Secretary | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Wilson
BRD | Director/Board Member | 61 | 16/06/16 |
Alan Fisher
CHM | Chairman | 71 | 01/09/16 |
Jane Ryan
BRD | Director/Board Member | 65 | 01/10/20 |
Aaron Weaver
BRD | Director/Board Member | 43 | 06/07/20 |
Chief Executive Officer | 52 | 05/01/23 | |
Peter Davies
BRD | Director/Board Member | 43 | 01/07/21 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-45,95% | 8,55 M | |
+15,55% | 121 Md | |
+12,66% | 107 Md | |
-2,53% | 24,82 Md | |
+1,08% | 22,48 Md | |
-9,47% | 18,32 Md | |
-42,28% | 16,33 Md | |
-18,92% | 15,31 Md | |
+6,19% | 14,08 Md | |
+28,83% | 11,74 Md |
- Bourse
- Actions
- Action BNOX
- Société Bionomics Limited